Cleveland Clinic Cancer Center announced the following new staff appointments:
Paolo Caimi—associate director for BMT and cellular therapyCaimi, a member of Cleveland Clinic’s lymphoma program, has clinical and research interest in lymphoid malignancy, with a focus on early phase studies and trials of cell therapy for relapsed and refractory lymphomas. Caimi was most recently section head of hematology at University Hospitals Cleveland Medical Center and medical director of the Clinical Trials Unit of University Hospitals Seidman Cancer Center. Kaleena Chilcote—director of psycho-oncology in the Department of Palliative and Supportive CareChilcote, who focuses on managing the neuropsychiatric side effects of cancer treatments and in medical education across disciplines, has experience directing mental health programs at the UPMC Hillman Cancer Center and WVU Cancer Institute. Joel Saltzman—director of regional clinical trialsSaltzman has clinical interests in GI cancers and prostate cancer. Previously, he practiced for 18 years at University Hospitals of Cleveland and Lake Health. Saltzman is also immediate past chair of the clinical practice committee of the American Society of Clinical Oncology.
